Regional inequalities threatening Europe’s biosimilars market
European Pharmaceutical Review
NOVEMBER 16, 2023
With procurement practices across Europe having a strong price focus, over time, this could impact the “sustainability of biosimilars and decrease competition, as well as reducing supply reliability”, the report acknowledged. “As Act4Biosimilars is supported by its founding sponsor, Sandoz.
Let's personalize your content